FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05135091 |
|
Recruitment Status :
Recruiting
First Posted : November 26, 2021
Last Update Posted : March 21, 2023
|
Sponsor:
Neurona Therapeutics
Collaborator:
California Institute for Regenerative Medicine (CIRM)
Information provided by (Responsible Party):
Neurona Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2025 |
| Estimated Study Completion Date : | May 2026 |